Jeff Auxier's AMGN Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 8,910 shares of Amgen Inc. (AMGN) worth $2.92 M, representing 0.41% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Jeff Auxier has maintained a strategic position in AMGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2021, adding 3,456 shares. Largest reduction occurred in Q1 2020, reducing 1,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -200 | Reduce 2.20% | 8,910 | $327.31 |
| Q2 2025 | -125 | Reduce 1.35% | 9,110 | $279.21 |
| Q1 2025 | -50 | Reduce 0.54% | 9,235 | $311.55 |
| Q4 2024 | +575 | Add 6.60% | 9,285 | $260.64 |
| Q3 2024 | -5 | Reduce 0.06% | 8,710 | $322.21 |
| Q2 2024 | -300 | Reduce 3.33% | 8,715 | $312.45 |
| Q4 2023 | -375 | Reduce 3.99% | 9,015 | $288.02 |
| Q3 2023 | -18 | Reduce 0.19% | 9,390 | $268.76 |
| Q2 2023 | +300 | Add 3.29% | 9,408 | $222.02 |
| Q1 2023 | +200 | Add 2.25% | 9,108 | $241.75 |
| Q4 2021 | +204 | Add 2.34% | 8,908 | $224.97 |
| Q3 2021 | +3,456 | Add 65.85% | 8,704 | $212.66 |
| Q1 2021 | +120 | Add 2.34% | 5,248 | $248.86 |
| Q3 2020 | -30 | Reduce 0.58% | 5,128 | $254.10 |
| Q1 2020 | -1,000 | Reduce 16.24% | 5,158 | $202.79 |
| Q4 2019 | -50 | Reduce 0.81% | 6,158 | $241.15 |
| Q3 2019 | +100 | Add 1.64% | 6,208 | $193.46 |
| Q4 2018 | -20 | Reduce 0.33% | 6,108 | $194.66 |
| Q2 2018 | +1,070 | Add 21.15% | 6,128 | $184.56 |
| Q1 2018 | +1,718 | Add 51.44% | 5,058 | $170.42 |
| Q4 2017 | +40 | Add 1.21% | 3,340 | $173.95 |
| Q2 2017 | +2,000 | Add 153.85% | 3,300 | $172.12 |
| Q1 2017 | +1,300 | New Buy | 1,300 | $163.85 |
Jeff Auxier's Amgen Investment FAQs
Jeff Auxier first purchased Amgen Inc. (AMGN) in Q1 2017, acquiring 1,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Amgen Inc. (AMGN) for 36 quarters since Q1 2017.
Jeff Auxier's largest addition to Amgen Inc. (AMGN) was in Q3 2021, adding 8,704 shares worth $1.85 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 8,910 shares of Amgen Inc. (AMGN), valued at approximately $2.92 M.
As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.41% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Amgen Inc. (AMGN) was 9,408 shares, as reported at the end of Q2 2023.